Biotech news
Americas
Biopharmaceutical company Amgen and drug manufacturer Arrowhead Pharmaceuticals have entered into two agreements to develop and commercialise RNA interference therapies for cardiovascular disease. 3 October 2016
Pharma
Biotechnology company Oncodesign is set to acquire pharmaceutical company GSK’s François Hyafil Research Centre in Essonne, France. 29 September 2016
Pharma
Clifford Chance has hired Stephen Reese as a partner in the firm’s London office. 28 September 2016
Americas
Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture. 28 September 2016
Pharma
UK-based law firm Potter Clarkson has expanded its intellectual property practice by hiring Nick McDonald and Richard Roberts as a partners and Oliver Laing as a senior associate. 27 September 2016
Americas
The US Food and Drug Administration has approved a biosimilar application by pharmaceutical company Amgen, the fourth such product to be rubberstamped in the country. 26 September 2016
Africa
Teva and Regeneron Pharmaceuticals have combined to develop and commercialise fasinumab, a novel nerve growth factor (NGF) antibody. 22 September 2016
Americas
Allergan has entered into an agreement to acquire Tobira Therapeutics for up to $1.7 billion. 22 September 2016
Biotech
In a session moderated by Dominic Adair of Bristows, panellists at the 2016 AIPPI World Congress in Milan yesterday discussed biosimilars substitution and interchangeability. 20 September 2016
Pharma
Ahead of the Life Sciences IP Summit 2016 from October 20 to 21 at the Hilton London Paddington Hotel, Sarah Porch of C5 previews the main talking points, including Brexit and the UPC. 16 September 2016